We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026

Demand Grows for Orthopedic Biomaterials in Europe

By HospiMedica staff writers
Posted on 25 Jul 2006
Changing demographics and lifestyle habits are increasing the incidence of typically age-related diseases, driving demand for orthopedic biomaterials across all age groups throughout Europe, according to a new report from Frost & Sullivan (Palo Alto, CA, USA), an international consulting firm.

As a result, Frost & Sullivan analyst Eleni Grammenou finds that the European orthopedic biomaterials market revenues are expected to rise from U.S.$240 million in 2005 to an estimated $609 million in 2012.

As Europe's population ages, it will be accompanied by a surge in age-related orthopedic conditions and various musculoskeletal diseases. More...
Likewise, traditionally age-related conditions such as osteoporosis and osteoarthritis will steadily increase among the younger population due to lifestyle changes such as smoking and poor nutrition, with sports and traffic-related injuries also claiming their toll on this group.

"The use of biomaterials has shown considerable clinical advantages and has been found to be particularly useful in a range of orthopedic applications including synthetic bone grafts, degradable fixation, and bone fillers,” said Mr. Grammenou. "Orthopedic biomaterials have also been found particularly useful in cranio-maxillofacial applications.”

However, the anticipated increase in demand will be challenged by cost-containment strategies affecting purchasing trends in the orthopedic braces and supports market, an alternative treatment option. In many cases, cost-cutting strategies being implemented by governments are driving hospitals to consider re-using orthopedic braces and support devices in an attempt to curb expenditures. These efforts will also affect the market for European orthopedic biomaterials.




Related Links:
Frost & Sullivan

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Examination & Procedure Light
Vega 80
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image Credit: 123RF

Existing Cardiovascular Risk Calculators Predict Several Common Cancers

Cardiovascular risk calculators are embedded in primary and secondary care to estimate 10‑year risk of heart attack or stroke from factors such as age, body mass index, and smoking. Many of these same... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.